Dual-use life sciences research can yield breakthroughs that improve health and the environment while also creating materials or knowledge that could be misapplied. Addressing these risks requires integrated policies, professional norms, and practical safeguards that preserve scientific progress while minimizing harm. Evidence-based approaches emphasize anticipatory assessment, transparent governance, and global cooperation.
Strengthening oversight and risk assessment
A foundational step is robust, ongoing risk-benefit assessment at the laboratory and funding stages. The National Research Council committee led by Gerald Fink at the Whitehead Institute and Massachusetts Institute of Technology recommended frameworks for evaluating experiments that might enable misuse, highlighting that early review reduces downstream harms. Complementing structural review, scholars such as Marc Lipsitch at Harvard T.H. Chan School of Public Health and Tom Inglesby at the Johns Hopkins Center for Health Security have advocated for rigorous, case-by-case evaluation of potential harms and mitigation strategies before work begins, rather than relying on retrospective controls. Practical measures include strengthened institutional biosafety committees with external expertise, mandatory training in responsible conduct, and pre-registration of protocols for particularly sensitive work. Such mechanisms do not eliminate risk, but they shift decision-making earlier and make tradeoffs explicit.
Publication, communication, and managed transparency
Decisions about dissemination are central to dual-use risk management. Journals, funders, and institutions must balance open science norms with the potential for enabling misuse. Empirical and policy analyses by established biosecurity authorities suggest options such as redacted methods sections, staged release of data, or targeted communication with trusted public health partners. These options require transparent governance so that decisions are consistent and defensible, avoiding ad hoc censorship that could undermine trust. Managing transparency well preserves legitimate scientific collaboration while acknowledging real security concerns.
Cultural and territorial contexts matter for implementation. Low-resource institutions and countries may lack biosafety infrastructure or regulatory capacity, increasing vulnerability to both accidental release and coercive misuse. Capacity building, technology transfer that emphasizes safety, and inclusive international standards can prevent inequitable burdens where researchers in wealthier settings export risk. Indigenous and local communities affected by research must be engaged in culturally appropriate ways, because social acceptability affects both uptake of safeguards and long-term stewardship.
Consequences of inadequate controls range from laboratory accidents to deliberate misuse, erosion of public trust in science, and restrictive policies that slow beneficial research. To reduce these outcomes, stakeholders across academia, industry, journals, and government must share responsibility. Funders can require risk assessment and mitigation plans, journals can develop clear editorial policies, and national advisory bodies such as the National Science Advisory Board for Biosecurity can provide guidance and harmonize standards.
Ultimately, addressing dual-use risks is both technical and ethical. Combining expert assessment, institutional accountability, international coordination, and sustained public engagement creates a resilient system that supports innovation while protecting society from foreseeable harms. This balanced approach accepts uncertainty but prioritizes preparedness and equitable governance.